Lifecore Biomedical, Inc. (LFCR) fundamentals score
Lifecore Biomedical, Inc. and its subsidiaries, located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials and cartridges, across a wide variety of modalities.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 3.7 out of 10, Weak long-term fundamentals
- Growth: 2.9/10
- Profitability: 3.0/10
- Financial health: 3.0/10
- Earnings quality: 7.6/10
- Valuation: 3.1/10
Scores are calculated from Lifecore Biomedical, Inc.’s SEC filings, using the 12 months through 2025-09. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10